Patch clamp study of benzydamine effect over neuronal excitability on inflammation sensitized rat nociceptors.

Abstract

Benzydamine (BZ) is an active principle with local anti-inflammatory effect and analgesic properties widely used in oral affections. BZ mechanism of action has been deeply characterized on inflammatory cell types and mediators, highlighting its capacity to inhibit pro-inflammatory mediator's synthesis and release. Nevertheless, its pharmacological action as analgesic has been slightly explored, even more in inflammatory condition, and a more precise understanding of its action at single cell level is needed. To better understand BZ effect on isolated nociceptors, single cell neuronal activity was studied by patch clamp after acute or chronic inflammatory sensitization. Consequently, DRG nociceptors were challenged either by 5-minutes or 24-hours incubation with an inflammatory soup (IS - containing histamine, serotonin, ATP and PGE2), or BZ, or simultaneously with IS and BZ. BZ acute application demonstrated a decrease in action potential firing frequency supported also by rheobase increase and afterhyperpolarization (AHP) amplitude increase. Acute BZ application simultaneously with IS, limited neuronal sensitization contrary to the effect observed after IS application alone, which increased twice the action potential firing frequency. Moreover, chronic incubation of BZ tended to protect neurons against inflammatory sensitization. These results reinforce a previous MEA study, demonstrating a reduction of neuronal excitability elicited by inflammatory mediators after BZ use.As a conclusion we hypothesize that the observed decrease in firing frequency and rheobase increase could be related to the direct inhibition of Nav 1.8 and 1.9 channels, while the changes in AHP could relate with HCN or Kv7 channels modulation. An action via proalgesic channels like ASIC or TRP, sensitized by the inflammatory environment, cannot be excluded. Overall results reinforce the analgesic and anti-inflammatory effect of benzydamine, supporting the complementary action of the compound on local pain signalling and inflammatory conditions.